Literature DB >> 20851784

Effects of the antiarrhythmic drug dofetilide on transmural dispersion of repolarization in ventriculum. A computer modeling study.

Javier Saiz1, Julio Gomis-Tena, Marta Monserrat, Jose M Ferrero, Karen Cardona, Javier Chorro.   

Abstract

Dofetilide is a class-III drug that inhibits the rapid component of the delayed potassium current ( I(Kr)). Experimental studies have shown that the different layers of ventricular muscle present differences in action potential duration (APD) and different responses to class III agents. It has been suggested that it contributes to APD heterogeneity in the ventricles. However, in vivo studies suggest that the strong cellular coupling reduces APD dispersion in intact heart. The aim of this paper is to study the effect of dofetilide on the action potentials (APs) in isolated ventricular cells and on APD dispersion in a strand of ventricular tissue. A mathematical model of dofetilide effects on I(Kr) has been developed and incorporated into the Luo--Rudy dynamic model of ventricular AP. Our results show that dofetilide induces in midmyocardium cells a faster time-course inhibition of I(Kr) than in endocardial or epicardial cells, and periods of instability with beat-to-beat APs variability. This behavior could favor temporal dispersion of repolarization between the different cells. The results also indicate that although dofetilide increases, the transmural gradient of APD in the ventricular wall, early afterdepolarizations (EADs) did not appear even under strong uncoupling conditions. However, reduced repolarization reserve favors the induction of EADs, even under normal coupling conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851784     DOI: 10.1109/TBME.2010.2077292

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  12 in total

1.  In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.

Authors:  Lucia Romero; Beatriz Trenor; Pei-Chi Yang; Javier Saiz; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

2.  In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.

Authors:  Lucia Romero; Beatriz Trenor; Pei-Chi Yang; Javier Saiz; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2015-10       Impact factor: 5.000

3.  Reduced response to IKr blockade and altered hERG1a/1b stoichiometry in human heart failure.

Authors:  Katherine M Holzem; Juan F Gomez; Alexey V Glukhov; Eli J Madden; Aaron C Koppel; Gregory A Ewald; Beatriz Trenor; Igor R Efimov
Journal:  J Mol Cell Cardiol       Date:  2015-06-17       Impact factor: 5.000

4.  Novel approaches to assessing cardiac safety--proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs.

Authors:  Katherine Fletcher; Rashmi R Shah; Arthur Thomas; Frank Tobin; Blanca Rodriguez; Gary R Mirams; Javier Saiz; Denis Noble
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 5.  The virtual heart as a platform for screening drug cardiotoxicity.

Authors:  Yongfeng Yuan; Xiangyun Bai; Cunjin Luo; Kuanquan Wang; Henggui Zhang
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

6.  In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.

Authors:  Cunjin Luo; Kuanquan Wang; Henggui Zhang
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

Review 7.  In Vitro and In Silico Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details.

Authors:  William Lee; Monique J Windley; Jamie I Vandenberg; Adam P Hill
Journal:  Front Physiol       Date:  2017-11-16       Impact factor: 4.566

Review 8.  Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges.

Authors:  Márcia Vagos; Ilsbeth G M van Herck; Joakim Sundnes; Hermenegild J Arevalo; Andrew G Edwards; Jussi T Koivumäki
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

9.  A three-dimensional human atrial model with fiber orientation. Electrograms and arrhythmic activation patterns relationship.

Authors:  Catalina Tobón; Carlos A Ruiz-Villa; Elvio Heidenreich; Lucia Romero; Fernando Hornero; Javier Saiz
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials.

Authors:  Nejib Zemzemi; Miguel O Bernabeu; Javier Saiz; Jonathan Cooper; Pras Pathmanathan; Gary R Mirams; Joe Pitt-Francis; Blanca Rodriguez
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.